hcwhealthcar
workermerscovmiddl
east
respiratori
syndrom
coronaviruspcrpolymeras
chain
reactionwhoworld
health
organ
sinc
epidemiolog
case
middl
east
respiratori
syndrom
coronaviru
merscov
infect
report
world
health
organ
character
larg
recurr
zoonot
spillov
known
anim
humantohuman
transmiss
healthcar
set
outbreak
healthcar
set
occas
result
larg
outbreak
case
includ
death
report
case
report
kingdom
saudi
arabia
clinic
present
merscov
infect
rang
asymptomat
sever
respiratori
ill
approxim
case
result
death
role
asymptomat
subclin
infect
humantohuman
transmiss
merscov
well
understood
evid
laboratoryconfirm
merscov
infect
patient
report
asymptomat
may
transmit
individu
mani
novel
infecti
pathogen
surveil
initi
focus
individu
diseas
seek
care
healthcar
facil
undoubtedli
underestim
true
preval
infect
account
mild
asymptomat
infect
requir
medic
care
detail
outbreak
investig
often
includ
laboratori
test
close
contact
healthcar
worker
hcw
regardless
symptom
special
serolog
investig
includ
individu
thought
higher
risk
infect
hcw
occup
exposur
anim
reservoir
estim
true
preval
infect
highrisk
pathogen
import
understand
popul
requir
vaccin
candid
specif
therapeut
treatment
becom
avail
addit
role
subclin
asymptomat
infect
critic
understand
chain
transmiss
miss
surveil
system
merscov
asymptomat
infect
report
possibl
transmiss
prior
symptom
onset
critic
recommend
effect
infect
prevent
control
measur
reduc
secondari
merscov
transmiss
role
asymptomat
infect
transmiss
respiratori
virus
investig
previous
highli
pathogen
avian
influenza
rna
exampl
detect
polymeras
chain
reaction
pcr
asymptomat
famili
contact
ill
patient
suggest
possibl
onward
transmiss
even
absenc
symptom
sever
acut
respiratori
syndrom
cov
limit
transmiss
close
contact
symptom
onset
hospit
found
transmissionrisk
studi
outsid
healthcar
set
wherea
humantohuman
transmiss
within
healthcar
set
higher
like
due
higher
viral
load
hospit
patient
frequent
exposur
viru
among
hcw
review
avail
evid
extent
subclin
asymptomat
infect
merscov
stratifi
evalu
studi
infect
within
outsid
healthcar
set
measur
potenti
role
onward
humantohuman
transmiss
asymptomat
case
conduct
literatur
search
pubm
embas
databas
observ
epidemiolog
studi
laboratoryconfirm
merscov
infect
use
follow
search
term
merscov
mer
seropreval
preval
serolog
infect
asymptomat
addit
studi
identifi
consult
mer
technic
network
bibliographi
relat
recent
publish
review
public
english
date
novemb
consid
addit
restrict
year
public
assess
titl
abstract
identifi
studi
determin
elig
inclus
studi
stratifi
analys
evalu
subclin
andor
asymptomat
infect
identifi
insid
outsid
healthcar
facil
descript
analysi
casebas
data
use
r
version
r
foundat
statist
comput
vienna
austria
merscov
infect
studi
outsid
healthcar
set
includ
studi
evid
merscov
infect
report
use
molecular
andor
serolog
method
either
individu
occup
exposur
dromedari
camel
famili
occup
social
contact
patient
confirm
mer
outsid
healthcar
set
gener
popul
nation
mer
surveil
record
publish
elig
studi
includ
report
number
individu
test
number
molecular
serolog
evid
merscov
infect
evalu
merscov
infect
studi
within
healthcar
set
includ
studi
author
report
evid
merscov
infect
use
molecular
andor
serolog
method
among
hcw
among
nonhcw
contact
eg
famili
contact
confirm
mer
case
treat
health
care
set
elig
studi
extract
inform
year
public
year
biolog
sampl
collect
countri
studi
conduct
number
individu
test
characterist
individu
test
total
number
confirm
merscov
infect
molecular
serolog
assay
asymptomat
merscov
infect
consid
laboratoryconfirm
infect
report
symptom
time
sampl
addit
evalu
symptomat
profil
place
report
among
laboratoryconfirm
merscov
infect
report
septemb
novemb
within
databas
case
classifi
primari
case
report
report
member
state
direct
indirect
contact
dromedari
camel
dromedari
product
report
case
andor
exposur
investig
without
known
contact
patient
probabl
confirm
mer
case
classifi
secondari
case
due
humantohuman
transmiss
patient
report
recent
direct
contact
patient
known
merscov
infect
andor
identifi
household
occup
hcw
contact
patient
known
merscov
infect
found
studi
document
durat
viral
shed
asymptomat
mildli
symptomat
individu
among
asymptomat
pcrposit
merscov
infect
posit
revers
transcriptas
rt
pcr
result
report
day
initi
test
long
day
found
studi
molecular
serolog
evid
possibl
secondari
transmiss
asymptomat
individu
report
studi
conduct
part
investig
household
contact
upper
respiratori
tract
sampl
pcr
posit
addit
sampl
seroposit
use
recombin
immunofluoresc
plaqu
reduct
neutral
test
eleven
individu
report
symptom
time
sampl
inform
combin
epidemiolog
data
indic
peopl
could
involv
asymptomat
transmiss
within
household
found
studi
describ
molecular
evid
merscov
infect
among
asymptomat
individu
healthcar
set
infect
asymptomat
hcw
infect
merscov
investig
studi
evid
found
secondari
transmiss
hcw
contact
hcw
merscov
infect
review
found
studi
molecular
andor
serolog
evid
merscov
infect
report
outsid
healthcar
set
evid
merscov
infect
larg
focus
individu
occup
exposur
dromedari
result
date
heterogen
although
attempt
made
evalu
merscov
genet
divers
differ
seropreval
result
date
like
reflect
differ
select
characterist
dromedari
herd
human
test
avail
evid
merscov
epidemiolog
genet
characterist
suggest
differ
viru
abil
infect
human
evid
support
individu
occup
exposur
dromedari
higher
rate
seropreval
compar
household
contact
patient
confirm
merscov
infect
like
reflect
intens
unprotect
exposur
merscov
dromedari
secret
individu
subclin
infect
develop
diseas
like
occup
exposur
tend
younger
healthier
without
underli
highrisk
condit
hypertens
diabet
renal
failur
variat
seropreval
rate
studi
also
like
due
variat
methodolog
includ
time
sampl
collect
serolog
assay
use
interpret
assay
result
although
major
human
merscov
infect
report
countri
arabian
peninsula
particularli
kingdom
saudi
arabia
increas
evid
infect
dromedari
camel
herd
throughout
africa
south
asia
addit
serolog
molecular
epidemiolog
studi
dromedaryhuman
interfac
use
standard
approach
consist
methodolog
arabian
peninsula
africa
south
asia
need
understand
observ
whether
observ
differ
evid
infect
outsid
healthcar
set
may
attribut
genet
variat
viru
across
differ
geograph
region
andor
factor
behavior
human
popul
region
may
chang
suscept
infect
current
support
studi
underway
sever
countri
middl
east
africa
south
asia
extent
infect
occup
expos
person
evalu
result
studi
contribut
better
understand
geograph
reach
merscov
dromedari
human
within
healthcar
set
detect
asymptomat
pcrposit
infect
report
affect
member
state
also
document
publish
studi
although
onward
transmiss
investig
studi
research
captur
evid
rna
shed
suggest
humantohuman
transmiss
possibl
individu
sign
symptom
infect
support
evid
document
durat
viral
shed
beyond
week
patient
subclin
merscov
infect
time
evid
acut
asymptomat
merscov
infect
describ
review
repres
full
extent
subclin
infect
asymptomat
contact
clear
viru
quickli
symptomat
patient
antibodi
titer
former
like
lower
seroconvert
infect
patient
exhibit
symptom
time
repeat
biolog
specimen
collect
need
captur
viral
shed
antibodi
kinet
symptomat
asymptomat
contact
achiev
highrisk
contact
patient
confirm
merscov
infect
identifi
outbreak
test
use
molecular
serolog
laboratori
assay
regardless
whether
individu
exhibit
symptom
outbreak
set
without
inclus
test
contact
identif
chain
transmiss
may
incomplet
inde
latest
surveil
guidelin
recommend
contact
patient
laboratoryconfirm
mer
outsid
health
care
facil
place
activ
surveil
day
last
exposur
confirm
case
contact
symptom
respiratori
ill
test
merscov
infect
feasibl
recommend
followup
includ
molecular
test
regardless
develop
symptom
addit
studi
conduct
highrisk
worker
typic
includ
serolog
test
also
includ
molecular
test
upper
respiratori
sampl
attempt
captur
viral
carriag
despit
limit
current
knowledg
find
review
reinforc
evid
hcw
like
risk
merscov
infect
due
close
unprotect
contact
patient
mer
patient
prior
diagnosi
particularli
aerosol
procedur
perform
hcw
tend
younger
healthier
patient
sever
mer
develop
hcw
fewer
symptom
present
silent
risk
humantohuman
transmiss
other
among
hcw
contact
detail
studi
viral
shed
immun
respons
asymptomat
pcrposit
merscov
infect
urgent
need
conduct
outbreak
occur
enhanc
surveil
put
place
govern
hospit
offici
surveil
test
merscov
improv
substanti
sinc
viru
first
discov
affect
countri
visual
respiratori
triag
system
patient
enter
emerg
depart
introduc
emerg
depart
affect
countri
restructur
enhanc
triag
patient
respiratori
symptom
train
specif
infect
prevent
control
respiratori
pathogen
introduc
reintroduc
highrisk
area
hospit
high
turnov
hcw
audit
hospit
complianc
specif
infect
prevent
control
measur
regularli
perform
addit
systemat
test
hcw
extend
beyond
nurs
doctor
includ
recept
staff
cleaner
technician
forth
regardless
develop
symptom
requir
latest
infect
prevent
control
guidelin
hcw
kingdom
saudi
arabia
exampl
detect
subclin
asymptomat
infect
like
would
gone
undetect
past
outbreak
asymptomat
infect
may
play
role
extens
secondari
transmiss
healthcar
set
latest
guidelin
introduc
impact
polici
may
reflect
lower
peak
global
merscov
epidem
curv
sinc
without
level
contact
followup
commun
set
extent
asymptomat
infect
commun
remain
unknown
screen
hcw
exposur
patient
infect
merscov
may
feasibl
prevent
humantohuman
transmiss
healthcar
set
appear
effect
kingdom
saudi
arabia
affect
countri
infect
prevent
control
measur
introduc
screen
nonhcw
contact
healthcar
set
also
encourag
outsid
healthcar
set
feasibl
screen
may
reduc
particularli
given
difficulti
detect
asymptomat
infect
therefor
transmiss
merscov
outsid
healthcar
set
expect
continu
zoonot
spillov
dromedari
interrupt
